Exosomes for immuno-oncology and anti-inflammatory therapy
US12331100B2 · kind B2 · utility
0Cited by
6References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 26, 2022 |
| Grant date | Jun 17, 2025 |
| Priority date | — |
| Expiry date | Dec 28, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/60
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are extracellular vesicles comprising an immunomodulating component. Also provided are methods for producing the extracellular vesicles and methods for using the extracellular vesicles for treating cancer, GvHD, and autoimmune diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.